← All trials
NCT02976688
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2017
- Primary completion
- Jul 31, 2017
- Completion date
- Dec 31, 2017
- First posted
- Nov 29, 2016
- Last posted
- Nov 29, 2016
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Azienda Sanitaria ASL Avellino 2Lead sponsor
- Azienda Sanitaria ASL Avellino 2Reponsible party - principal investigator
- Azienda Sanitaria ASL Avellino 2Sponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.